Are IRBs Efficient, Effective, or Redundant? David C. Clark, Ph.D. Director, Research Compliance Rush University Center.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

Criteria For Approval 45 CFR CFR Minimized risks Reasonable risk/benefit ratio Equitable subject selection Informed consent process Informed.
NCVHS: Privacy and Confidentiality Leslie P. Francis, Ph.D., J.D. Distinguished Professor of Law and Philosophy Alfred C. Emery Professor of Law University.
The Institutional Review Board. What is an IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.
Clarity, consent and coverage for research-related injuries 6 th Annual Columbia University IRB Conference Boston, MA Patrick Taylor Children’s Hospital.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
Conflict and Consent: Managing Disclosure in Human Subjects Research University of Miami Human Subjects Research Office Conflict of Interest Symposium.
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
YALE MASTER SLIDE HERE Clinical Research Management – Is not just a handshake deal? Jamie Caldwell, MBA Director Office of Research Services for the Health.
CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.
Clarity, consent and coverage for research-related injuries 6 th Annual Columbia University IRB Conference Boston, MA Patrick Taylor Children’s Hospital.
Who Ultimately Protects Human Research Subjects? Presented by Bernard A Schwetz, D.V.M., Ph.D. Director Director Office for Human Research Protections.
Informed Consent and HIPAA Tim Noe Coordinating Center.
Human Investigation Committee  Is it research?  If yes, does it involve human subjects?  If yes, can it be exempt?  If no, will a Request for.
Internal Auditing and Outsourcing
IRBMED AND CHESAPEAKE IRB General Procedures for Ceding IRBMED Oversight Procedures Specific to Chesapeake IRB Medical School Institutional Review Board.
Contracts: Negotiations and Key Elements Belinda Vandersluis Operations Director, NCIC CTG.
Good Clinical Practice (GCP)- An introduction Dr Noor Ibrahim Mohamed Sakian.
IRB and the Community Member How You Can Get Involved Mary Lou Smith Elda Railey Conference Call Series on IRBs and Ethical Issues in Research Co-sponsored.
International Research & Research Involving Children K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development.
Yesterday, today, and tomorrow
ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight.
Institutional Research Compliance Juliann Tenney, JD Research Compliance and Privacy Officer Director, Institutional Research Compliance Program.
Institutional Review Board (IRB) for Human Subject Protections: Working with the IRB Erin McClure, PhD Department of Psychiatry and Behavioral Sciences.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Role of the Oncology Research Team Carmen B. Jacobs, BS, RN,OCN, CCRP U.T.M.D. Anderson Cancer Center Houston, Texas U.S.A.
Confidentiality Issues in Research with Human Subjects Sarah Frankel, Ph.D. Human Studies Committee Washington University.
Research Ethics & New Investigators Melody Lin, Ph.D. Dec. 12, 2012.
ORO Reviews: Frequent Findings Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight May, 2012.
Human Research Protection Program Training UCSF’s Subject Injury Program Wednesday, April 11, :30 am to 12:00 pm Carroll Child, RN, MSc. CCRP Clinical.
Research Compliance: An Overview of the Players and Issues Involved in Emory’s Research Compliance Programs.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
Institutional Review Board (IRB) What is our Purpose and Role for Ethical Research.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Managing Conflicts of Interest at the IRB and Institutional Level: INSTITUTIONAL CONFLICTS OF INTEREST Claudia R. Adkison, J.D., Ph.D. Executive Associate.
A Primer on Clinical Trials for the Research Administrator
Human Research Protection Program & IRB Responsibilities Marisue Cody, PhD Director Center on Advice & Compliance Help.
Integrating a Federated Healthcare Data Query Platform With Electronic IRB Information Systems Shan He IPHIE 2010.
Yadvindera (Bobby) Bains MD Director of Radiation Oncology, Laredo Medical Center Adjunct Associate Professor, Dept of Radiation Oncology, University of.
Health Insurance portability and Accountability Act (HIPAA)‏
AAHRPP ACCREDITATION (Association for the Accreditation of Human Protection Programs)
What Institutional Researchers Should Know about the IRB Susan Thompson Senior Research Analyst Office of Institutional Research Presented at the Texas.
CUNY Human Research Protection Program (HRPP) School of Professional Studies April 18, 2013
Inside Clinical Trials ® ALL RIGHTS RESERVED. What is a clinical trial? ALL RIGHTS RESERVED.
APPROVAL CRITERIA AN IRB INFOSHORT MAY CFR CRITERIA FOR IRB APPROVAL OF RESEARCH In order for an IRB to approve a research study, all.
Conflicts of Interest in Research : Perspective of the IRB Human Subject Protections Monika S. Markowitz, PhD Director, Office of Research Compliance and.
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.
Emerging SACHRP Issues K. Lynn Cates, MD Assistant Chief Research & Development Officer Director, PRIDE Office of Research & Development Department of.
Second Annual Medical Research Summit March 25, 2002 Washington, D.C.
Medical Research in Times of Bioterrorism - OHRP’s Perspective Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.
Legal Responsibilities for Studies Conducted or Supported by HHS Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.
Marianne M. Elliott Office of Research Integrity and Ethics Bureau of Medicine and Surgery U. S Navy.
THE INSTITUTIONAL REVIEW BOARD. WHAT IS AN IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.
Institutional Review Board (IRB) for Human Subject Protections: Working with the IRB Erin A McClure, PhD Department of Psychiatry and Behavioral Sciences.
Current Challenges & Opportunities in Clinical Research Compliance.
IRB BASICS BETTY WILSON, MS, CIP. CONCEPTS SUBMISSION APPROVAL RECRUITING WORKING WITH PRINCIPAL INVESTIGATOR (PI) /SPONSOR POLICIES DEVIATIONS RECORD.
Cancer Clinical Trials Office Clinical Trials & Research Training Oct2014.
Data Integrity – The Basis for “Generalizability” to Substantiate Change Balancing Efficacy with Clinical Power Frederick A. Curro, DMD, PhD PEARL Network.
Susan Sonne, PharmD, BCPP Chair, MUSC IRB II
Research Compliance and Institutional Review Boards
The HIPAA Privacy Rule: Implications for Medical Research
How to Apply for and Receive Industry Funding for Investigator Sponsored Research Chuck Simonton MD, FACC, FSCAI Chief Medical Officer Abbott Vascular.
Investigator Responsibilities in Human Subjects Research
Investigator Responsibilities: What should we expect from researchers?
Streamlining IRB Procedures for Expanded Access
Subject Injury Policy, Identification, and Reporting at OHSU
Exploring 45 CFR , Criteria for IRB Approval of Research
Change to Commercial IRB Fees
Research with Human Subjects
Presentation transcript:

Are IRBs Efficient, Effective, or Redundant? David C. Clark, Ph.D. Director, Research Compliance Rush University Center

Efficient IRBs integrate their activities with... Senior Administration Research HIPAA Privacy policies Other local protection processes Conflict of Interest policies and Committee Clinical trial contract office Investigator clinical trial budgets

Relationship with Senior Administration Reinforcement of IRB’s value to the Institution Recognition for IRB service Sufficient expertise on the IRB Provision of adequate non-human resources Long-term planning with the IRB Collaborative problem-solving

Integrating HIPAA Privacy concerns Criteria for “Waiver of Authorization” Criteria for “de-identification” of all data Accessing clinical information to recruit for clinical trials Re-use of data stored in data/tissue repositories

Integrating other local protection processes Radiation Safety Committee (licensed by NRC) Radioactive Drug Research Committee (21 CFR 361.1) Institutional Biosafety Committee

Integrating Conflict of Interest / Individual Institutional and IRB policies Ability to bring data about financial relationships to bear on specific studies in timely manner Communication between Conflict of Interest Committee and IRB

Integrating Conflict of Interest / Institutional Institutional and IRB policies Ability to bring data about financial relationships to bear on specific studies in timely manner Communication between Conflict of Interest Committee and IRB Objectivity is more difficult

Two relevant AAMC Reports Protecting Subjects, Preserving Trust, Promoting Progress I: Policy and Guidelines for the Oversight of Individual Financial Interests in Human Subjects Research AAMC, December 2001 Task Force on Financial Conflicts of Interest in Clinical Research

Two relevant AAMC Reports Protecting Subjects, Preserving Trust, Promoting Progress II: Principles and Recommendations for Oversight of an Institution's Financial Interests in Human Subjects Research AAMC, October 2002 Task Force on Financial Conflicts of Interest in Clinical Research

INFORMED CONSENT DOCUMENTS: Patient’s responsibility for trial costs the following elements of information shall also be provided to each subject: (3) Any additional costs to the subject that may result from participation in the research. (FDA) 21 CFR b.3

INFORMED CONSENT DOCUMENTS: Patient’s responsibility for trial costs Should “costs to my insurance company” be considered “costs to me?” –I pay the insurance premiums –I pay the deductibles, co-pays, and remainders –My insurance expenses (today) sometimes limit my access to future insurance coverage –If my insurance doesn’t pay, I could get stuck with a very large bill

INFORMED CONSENT DOCUMENTS: Medical care for adverse consequences (Issue:) Does fault lie with product/participation or with Investigator? “Contract should contain prohibition against billing of patient’s insurer.” “Sponsors should not place dollar caps on medical treatment for adverse consequences.”

INFORMED CONSENT DOCUMENTS: Patient’s responsibility for trial costs “In no case should Sponsors require the Institution to bill the cost of subject’s injury that is a consequence of trial participation to the subject’s insurance company, then only pay for what is NOT covered by insurance.” “Ethically unacceptable.” AAMC, January 2004

New AAMC Report Clinical Trial Contracts: A Discussion of Four Selected Provisions AAMC, January 2004 Baer, Feiler, Regulski, and Switzer

INFORMED CONSENT DOCUMENTS: Patient’s responsibility for trial costs Contract or practice that seeks to bill subject’s insurance company (and requires documentation of “failure to pay”) before Sponsor assumes any responsibility for expenses -- is this ethical? –Some patients pay via insurance premiums and co- pays while others do not -- is this equitable? –Means of including patients and providing clinical care to those who otherwise could not afford.